Want to see AU:EVE full AI Analyst Report?
EVE Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)430.04K
Market Cap
AU$5.99M
Enterprise ValueAU$4.86
Total Cash (Recent Filing)AU$1.24M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,326,600
10 Day Avg. Volume337,181
30 Day Avg. Volume430,043
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.40
Price to Sales (P/S)4.80
P/FCF Ratio-3.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetMinimal debt and positive equity provide a financial buffer while EVE restructures, reducing refinancing and interest-rate exposure. This conservative capital structure can preserve strategic flexibility over the next several quarters, although losses still weigh on returns.
Narrowing LossesLosses have narrowed materially from the very weak 2022–2023 results, indicating some improvement in the earnings trajectory. If maintained, this could reduce the distance to break-even and support a more sustainable business model, despite current losses.
Focused Consumer Health PortfolioEVE operates in the branded consumer health products sector, with a portfolio historically centered on women's health supplements and wellness offerings. A focused category proposition can support repeat product development and distribution, though the pack does not show current growth.
Bears Say
Sustained Revenue ContractionRevenue has declined for several consecutive years, including a 15.29% fall in 2026. Persistent contraction signals weakening scale and reduces operating leverage, making it harder for the company to spread costs, rebuild margins, and reach break-even over the next several quarters.
Severe Profitability PressurePersistent operating and net losses, together with deeply negative margins and negative gross profit in 2026, show that sales are not covering the cost base. Until gross profitability returns, EVE's ability to reinvest and become self-funding remains structurally constrained.
Persistent Cash BurnOperating cash flow and free cash flow have been below zero every year, so the business is consuming rather than generating cash internally. Continued burn can require external funding or balance-sheet resources, limiting resilience and reducing flexibility to execute the product strategy.
EVE Health Group Limited News
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$5.99M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Mar 01, 2027 which is in 167 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.003 earnings per share for the quarter.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 352,326,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.003 in its last earnings report. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EVE Health Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.61%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
EVE Health Group Limited
Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.
Technical Analysis
Australian Dairy Nutritionals Group
―
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―